S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7)

Bibliographic Details
Main Authors:	A. Sureda, J. Westin, F. L. Locke, M. Dickinson, A. Ghobadi, M. Elsawy, T. van Meerten, D. B. Miklos, M. Ulrickson, M.-A. Perales, U. Farooq, L. Wannesson, L. Leslie, M. J. Kersten, C. A. Jacobson, J. M. Pagel, G. Wulf, P. Johnston, A. P. Rapoport, L. I. Gordon, Y. Yang, A. Peng, L. Du, J. T. Snider, J. Shah, M. Schupp, P. Cheng, C. To, O. O. Oluwole
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843736.56298.a7

Internet